Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Diplomat Pharmacy Inc (DPLO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 402,991
  • Shares Outstanding, K 74,490
  • Annual Sales, $ 5,493 M
  • Annual Income, $ -302,270 K
  • 60-Month Beta 0.72
  • Price/Sales 0.07
  • Price/Cash Flow 1.13
  • Price/Book 0.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.07
  • Number of Estimates 7
  • High Estimate 0.10
  • Low Estimate 0.03
  • Prior Year 0.20
  • Growth Rate Est. (year over year) -65.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.99 +8.42%
on 04/17/19
6.41 -15.60%
on 03/21/19
-0.39 (-6.72%)
since 03/18/19
3-Month
4.99 +8.42%
on 04/17/19
14.53 -62.77%
on 01/31/19
-8.08 (-59.90%)
since 01/18/19
52-Week
4.99 +8.42%
on 04/17/19
28.74 -81.18%
on 06/22/18
-16.31 (-75.09%)
since 04/18/18

Most Recent Stories

More News
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, WTW, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

CTL : 12.14 (+0.25%)
WTW : 19.07 (-2.41%)
BA : 380.07 (+0.68%)
DPLO : 5.41 (+3.84%)
DPLO DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Diplomat Pharmacy, Inc. - DPLO

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019,...

DPLO : 5.41 (+3.84%)
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

CVS : 52.63 (+0.17%)
BPI : 6.39 (unch)
BA : 380.07 (+0.68%)
DPLO : 5.41 (+3.84%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Diplomat Pharmacy, Inc. of Class Action Lawsuit and Upcoming Deadline - DPLO

Pomerantz LLP announces that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. ("Diplomat" or the "Company") (NYSE: DPLO) and certain of its officers and directors. The class action,...

DPLO : 5.41 (+3.84%)
CLASS ACTION UPDATE for CORT, AVEO, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

CORT : 11.96 (+0.25%)
AVEO : 1.01 (-8.18%)
MBT : 8.09 (+1.13%)
DPLO : 5.41 (+3.84%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Health Insurance, Kraft Heinz, Diplomat, and Stamps.com and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Health Insurance Innovations, Inc., The Kraft Heinz Company, Diplomat Pharmacy,...

STMP : 79.40 (-0.16%)
KHC : 32.96 (+0.21%)
HIIQ : 23.85 (-0.42%)
DPLO : 5.41 (+3.84%)
Diplomat to Release First-Quarter 2019 Operating Results May 7, Participate in Bank of America Merrill Lynch Healthcare Conference May 14

Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its first-quarter 2019 operating results before market open Tuesday, May 7. A conference call and live webcast will be held at 8:30 a.m. ET.

DPLO : 5.41 (+3.84%)
DIPLOMAT APRIL 25th ALERT: Rosen Law Firm Reminds Diplomat Pharmacy, Inc. Investors of Important Deadline in Securities Class Action Filed by the Firm - DPLO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Diplomat Pharmacy, Inc. (NYSE: DPLO) from February 26, 2018 through February 21, 2019, inclusive (the "Class Period")...

DPLO : 5.41 (+3.84%)
DPLO CLASS ACTION REMINDER: Hagens Berman Reminds Diplomat Pharmacy (DPLO) of Securities Class Action, Encourages Investors to Contact the Firm

Hagens Berman Sobol Shapiro LLP reminds investors in Diplomat Pharmacy, Inc. (NYSE: DPLO) of the pending securities class action and the April 25, 2019 Lead Plaintiff deadline. If you purchased or otherwise...

DPLO : 5.41 (+3.84%)
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

CVS : 52.63 (+0.17%)
CTL : 12.14 (+0.25%)
BA : 380.07 (+0.68%)
DPLO : 5.41 (+3.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade DPLO with:

Business Summary

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including...

See More

Key Turning Points

2nd Resistance Point 5.58
1st Resistance Point 5.50
Last Price 5.41
1st Support Level 5.27
2nd Support Level 5.12

See More

52-Week High 28.74
Fibonacci 61.8% 19.67
Fibonacci 50% 16.86
Fibonacci 38.2% 14.06
Last Price 5.41
52-Week Low 4.99

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar